Marina Pellón-Consunji
AeroLeads people directory · profile

Marina Pellón-Consunji Email & Phone Number

Partner at Ampersand Capital Partners at Ampersand Capital Partners
Location: Amsterdam, North Holland, Netherlands 10 work roles 7 schools
1 work email found @ampersandcapital.com LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email m****@ampersandcapital.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Partner at Ampersand Capital Partners
Location
Amsterdam, North Holland, Netherlands
Company size

Who is Marina Pellón-Consunji? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Marina Pellón-Consunji is listed as Partner at Ampersand Capital Partners at Ampersand Capital Partners, a with 29 employees, based in Amsterdam, North Holland, Netherlands. AeroLeads shows a work email signal at ampersandcapital.com and a matched LinkedIn profile for Marina Pellón-Consunji.

Marina Pellón-Consunji previously worked as Partner at Ampersand Capital Partners and Principal at Ampersand Capital Partners. Marina Pellón-Consunji holds B.A. Honors, Biological Chemistry And International Relations from Wellesley College.

Company email context

Email format at Ampersand Capital Partners

This section adds company-level context without repeating Marina Pellón-Consunji's masked contact details.

*@ampersandcapital.com
71% confidence

AeroLeads found 1 current-domain work email signal for Marina Pellón-Consunji. Compare company email patterns before reaching out.

Profile bio

About Marina Pellón-Consunji

Marina joined Ampersand in 2013. Prior to Ampersand she was an Associate Director in Healthcare Investment Banking at UBS where she worked on a number of leveraged buyouts, mergers and acquisitions and debt and equity financings for middle market healthcare companies. Prior to joining UBS, Marina worked at biochemistry laboratories at Harvard Medical School and Wellesley College. Marina holds a B.A. with Honors from Wellesley College where she majored in Biological Chemistry and International Relations.

Listed skills include Investment Banking, Lbo, Valuation, Mergers And Acquisitions, and 9 others.

Current workplace

Marina Pellón-Consunji's current company

Company context helps verify the profile and gives searchers a useful next step.

Ampersand Capital Partners
Ampersand Capital Partners
Partner at Ampersand Capital Partners
wellesley, massachusetts, united states
Employees
29
AeroLeads page
10 roles

Marina Pellón-Consunji work experience

A career timeline built from the work history available for this profile.

Partner

Current

Amsterdam, North Holland, Netherlands

Ampersand was founded in the late 1980s and began investing in healthcare in the early 1990s. Today, Ampersand is focused exclusively on growth equity investments in lower middle market healthcare companies. We are typically the first institutional investor in founder-owned businesses, where we work with the entrepreneur to help take the company to the next level.We focus on EBITDA-positive companies that provide products or services within several key healthcare sectors, including pharmaceutical services, contract manufacturing, laboratory testing services, and laboratory products.

Feb 2021 - Present

Board Member

Current

Heilbronn, Baden-Württemberg, Germany

Protagen Protein Services (PPS) is a world leading CRO and recognized expert in analytical services in protein science and gene therapy products. Over 20 years of market experience and the comprehensive spectrum of validated analytical methods ensure the highest quality for customers in the pharmaceutical, biotech and life science industry. The company is an excellent partner for the biopharmaceutical industry worldwide to benefit from the most advanced, integrated and complete analytic services capabilities and platforms in biopharmaceutical development, from clone selection through drug approval to commercialization. In working together with their pharmaceutical partners, the PPS teams generate best-in-class analytic data packages and provide scientific, technical and regulatory support to advance, de-risk and accelerate all stages of biopharmaceutical development by all-in-one-hand service with complete documentation and outstanding project management to gain market success.

Jul 2021 - Present

Board Member

Current

Heidelberg, Baden-Württemberg, Germany

GeneWerk provides cell and gene therapy sponsors with patient testing services in compliance with guidance by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). The company is recognized as a leading provider of vector integration site analysis (ISA) services, a method that was developed by GeneWerk's founders and that the FDA and EMA recommend performing after the administration of both integrating and non-integrating cell and gene therapies. The company's test menu also includes vector persistence testing, gene edited off-target analysis, vector copy number (VCN), vector quality control, immune repertoire analysis, and dedicated bioinformatics studies. With a focus on vector safety, characterization, and functionality analysis, the company's 30 employees work in compliance with GCP and in line with GLP standards in a BSL-2 classified state-of-the-art genomics and bioinformatics laboratory in Heidelberg, Germany.

Sep 2020 - Present

Board Member

Current

Cuxhaven Area, Germany

Vibalogics offers process development, manufacturing and fill & finish of products for biopharmaceutical companies involved in the development of oncolytic viral therapies, gene therapies, and vaccines. With a specific focus on viruses, live bacteria, and aseptic processing, the company’s 60 employees work in full compliance with international GMP standards in a BSL-2 classified state of the art, 30,000 sq. ft. facility in Cuxhaven, Germany.

May 2019 - Present

Board Member

Uppsala, Sweden

Gyros Protein Technologies is a leading provider of peptide synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. Formed in March 2016 by the merger of Gyros AB and Protein Technologies, Inc., the Company combines Gyros’ microfluidics, systems development and immunoassay expertise with Protein Technologies’ deep knowledge in developing and manufacturing instruments for peptide synthesis.With a large and growing installed base of instruments in the biopharmaceutical industry and related markets, Gyros Protein Technologies is leading its field in several key application areas in biotherapeutics, from research through Phase 4 clinical development and particularly in bioprocess. The Company holds a high growth, high margin product portfolio, including ~50% in recurring aftermarket consumables and service revenue, coupled with a reputation for exceptional customer service and support.

Jun 2018 - Oct 2019

Surgical Oncology Research Student

Beth Israel Deaconess Medical Center, Harvard Medical School

Greater Boston Area

Jul 2009 - Sep 2009
Team & coworkers

Colleagues at Ampersand Capital Partners

Other employees you can reach at ampersandcapital.com. View company contacts for 29 employees →

7 education records

Marina Pellón-Consunji education

B.A. Honors, Biological Chemistry And International Relations

Honors Thesis Defense: Cancer-Causing Mutations in the Heterodimerization Domain of Notch Proteins: Physicochemical Properties.

Education record

Colegio Base
FAQ

Frequently asked questions about Marina Pellón-Consunji

Quick answers generated from the profile data available on this page.

What company does Marina Pellón-Consunji work for?

Marina Pellón-Consunji works for Ampersand Capital Partners.

What is Marina Pellón-Consunji's role at Ampersand Capital Partners?

Marina Pellón-Consunji is listed as Partner at Ampersand Capital Partners at Ampersand Capital Partners.

What is Marina Pellón-Consunji's email address?

AeroLeads has found 1 work email signal at @ampersandcapital.com for Marina Pellón-Consunji at Ampersand Capital Partners.

Where is Marina Pellón-Consunji based?

Marina Pellón-Consunji is based in Amsterdam, North Holland, Netherlands while working with Ampersand Capital Partners.

What companies has Marina Pellón-Consunji worked for?

Marina Pellón-Consunji has worked for Ampersand Capital Partners, Protagen Protein Services Gmbh, Genewerk, Vibalogics, and Gyros Protein Technologies Ab.

Who are Marina Pellón-Consunji's colleagues at Ampersand Capital Partners?

Marina Pellón-Consunji's colleagues at Ampersand Capital Partners include Matthew Munfakh, Charles Yie, Madeline Brown-Scherer, Hidde Van Kerckhoven, and Léonard Vieilly.

How can I contact Marina Pellón-Consunji?

You can use AeroLeads to view verified contact signals for Marina Pellón-Consunji at Ampersand Capital Partners, including work email, phone, and LinkedIn data when available.

What schools did Marina Pellón-Consunji attend?

Marina Pellón-Consunji holds B.A. Honors, Biological Chemistry And International Relations from Wellesley College.

What skills is Marina Pellón-Consunji known for?

Marina Pellón-Consunji is listed with skills including Investment Banking, Lbo, Valuation, Mergers And Acquisitions, Capital Markets, Financial Analysis, Bloomberg, and Private Equity.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.